N-((Alkylamino)carbonyl)-N-(((alkylamino)carbonyl)oxy)acylamides

Details N-((Alkylamino)carbonyl)-N-(((alkylamino)carbonyl)oxy)acylamides N-((Alkylamino)carbonyl)-N-(((alkylamino)carbonyl)oxy)acylamides

1982-02-17

1983-11-01

Trousof, Natalie

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Recombinant or stably-transformed bacterium encoding one or...

260545R, A61K 31215, A61K 31325

Patent

active

044130090

ABSTRACT:
The present invention is directed to N-((alkylamino)carbonyl)-N-(((alkylamino)carbonyl)oxy)acylamides and their use in inhibiting the growth of HeLa cells, P.sub.388 leukemia or MX-1 carcinomas in mammals.

REFERENCES:
patent: 3836572 (1974-09-01), Franz
patent: 3957867 (1976-05-01), Bukowick
patent: 4030912 (1977-06-01), Bukowick
patent: 4207091 (1980-06-01), Fischer
Ogawa, Masami et al. Chemical Abstracts, vol. 86 (1977) #101,869w.

Affiliated with

Also associated with

Rating

N-((Alkylamino)carbonyl)-N-(((alkylamino)carbonyl)oxy)acylamides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-((Alkylamino)carbonyl)-N-(((alkylamino)carbonyl)oxy)acylamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-((Alkylamino)carbonyl)-N-(((alkylamino)carbonyl)oxy)acylamides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2168733